Biomarin Pharmaceutical Inc
BMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001048477
In the last 90 days, Biomarin Pharmaceutical Inc insiders filed 0 open-market purchases and 1 sale; 565 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; Viking Global Investors is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Biomarin Pharmaceutical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $1.16M in total
- Insiders trading
- 1
- Net value
- −$1.16M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Biomarin Pharmaceutical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Plenge Robert M | Director | 6,140 | Sep 14, 2026 | 1 |
| Davis George Eric | EVP, Chief Legal Officer | 61,003 | Sep 3, 2026 | 4 |
| Dere Willard H | Director | 46,440 | Jun 4, 2026 | 1 |
| Clark Ian T | Director | 14,490 | Jun 4, 2026 | 1 |
| Walbert Timothy P | Director | 17,270 | Jun 4, 2026 | 1 |
| Hombach Robert J. | Director | 49,360 | Jun 4, 2026 | 1 |
| Countouriotis Athena | Director | 21,040 | Jun 4, 2026 | 1 |
| Enyedy Mark J | Director | 21,040 | Jun 4, 2026 | 1 |
| Ho Maykin | Director | 35,500 | Jun 4, 2026 | 1 |
| Bodem Barbara W. | Director | 21,045 | Jun 4, 2026 | 1 |
| Anderson Elizabeth M | Director | 41,940 | Jun 4, 2026 | 1 |
| Hubbard Cristin | EVP, Chief Commercial Officer | 42,472 | May 21, 2026 | 2 |
| Friberg Gregory R | EVP, Chief R&D Officer | 51,818 | May 11, 2026 | 4 |
| Mueller Brian | EVP, Chief Financial Officer | 123,314 | Mar 19, 2026 | 3 |
| Guyer Charles Greg | EVP, Chief Technical Officer | 84,140 | Mar 19, 2026 | 4 |
| Hardy Alexander | Chief Executive Officer | 214,635 | Mar 19, 2026 | 3 |
| Ramchandani Rashmi Virendra | VP, Chief Accounting Officer | 25,610 | Jan 22, 2026 | 1 |
| Meier Richard A | Director | 127,426 | May 22, 2025 | 0 |
| Burkhart Erin | GVP, Chief Accounting Officer | 14,173 | May 20, 2025 | 0 |
| Fuchs Henry J | President, Worldwide R&D | 185,074 | Sep 17, 2024 | 0 |
| Heron Elaine J | Director | 97,720 | Jun 4, 2024 | 0 |
| Pyott David E I | Director | 49,750 | May 23, 2024 | 0 |
| Bienaime Jean Jacques | Director | 473,792 | May 21, 2024 | 0 |
| Ajer Jeffrey Robert | EVP, Chief Commercial Officer | 66,767 | May 6, 2024 | 0 |
| Slamon Dennis | Director | 31,299 | Mar 20, 2024 | 0 |
| Lawlis V Bryan | Director | 33,140 | May 24, 2023 | 0 |
| Alles Mark J | Director | 15,095 | May 24, 2023 | 0 |
| Acosta Andrea | GVP, Chief Accounting Officer | 18,122 | Jul 19, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2022 (view filing) | Oct 31 | 1 day | Bienaime Jean JacquesChief Executive Officer | SSale | −1.50K | $86.55 | −$129.8K | −0.5%322.8K after | |
| Oct 18, 2022 (view filing) | Oct 14 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −4.00K | $89.89 | −$359.6K | −1.2%324.3K after | |
| Aug 16, 2022 (view filing) | Aug 12-15 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −7.00K | $94.95 | −$664.6K | −2.1%328.3K after | 2 lots |
| Aug 12, 2022 (view filing) | Aug 11 | 1 day | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −3.00K | $95.62 | −$286.9K | −6.4%44.1K after | |
| Aug 11, 2022 (view filing) | Aug 9 | 2 days | Davis George EricEVP, Chief Legal Officer | SSale | −51.2K | $95.96 | −$4.91M | −48.1%55.3K after | 2 lots |
| Aug 10, 2022 (view filing) | Aug 8 | 2 days | Guyer Charles GregEVP, Chief Technical Officer | SSale | −6.21K | $96.56 | −$599.2K | −12.8%42.2K after | |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Mueller BrianEVP, Chief Financial Officer | SSale | −3.50K | $94.50 | −$330.8K | −10.2%30.7K after | |
| Jul 12, 2022 (view filing) | Jul 8 | 4 days | Mueller BrianEVP, Chief Financial Officer | SSale | −7.34K | $89.50 | −$656.7K | −19.3%30.7K after | |
| Jul 11, 2022 (view filing) | Jul 8 | 3 days | Davis George EricEVP, Chief Legal Officer | SSale | −7.40K | $90.00 | −$665.8K | −11.2%58.9K after | |
| May 31, 2022 (view filing) | May 26 | 5 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −1.31K | $78.94 | −$103.3K | −2.4%54.1K after | |
| May 9, 2022 (view filing) | May 5-6 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −30.0K | $82.05 | −$2.46M | −8.2%335.3K after | 2 lots |
| May 6, 2022 (view filing) | May 4 | 2 days | Mueller BrianEVP, Chief Financial Officer | SSale | −11.8K | $84.50 | −$997.1K | −23.4%38.6K after | 2 lots |
| May 4, 2022 (view filing) | May 2 | 2 days | Meier Richard ADirector | SSale | −3.88K | $82.09 | −$318.3K | −3.6%104.0K after | 2 lots |
| May 4, 2022 (view filing) | May 2 | 2 days | Davis George EricEVP, Chief Legal Officer | SSale | −15.3K | $80.38 | −$1.23M | −18.8%66.3K after | |
| May 2, 2022 (view filing) | Apr 28-29 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −25.0K | $83.42 | −$2.09M | −6.9%335.0K after | 2 lots |
| Apr 20, 2022 (view filing) | Apr 18 | 2 days | Bienaime Jean JacquesChief Executive Officer | SSale | −20.0K | $81.91 | −$1.64M | −5.6%335.0K after | |
| Apr 18, 2022 (view filing) | Apr 14 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −10.0K | $83.66 | −$836.6K | −2.9%335.0K after | |
| Apr 18, 2022 (view filing) | Apr 14 | 4 days | Lawlis V BryanDirector | SSale | −4.25K | $83.66 | −$355.6K | −15.1%24.0K after | |
| Apr 14, 2022 (view filing) | Apr 13 | 1 day | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −1.18K | $82.47 | −$97.3K | −2.1%55.1K after | |
| Mar 31, 2022 (view filing) | Mar 29-30 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −3.00K | $79.49 | −$238.4K | −5.1%56.3K after | 2 lots |
| Mar 24, 2022 (view filing) | Mar 22-23 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −8.20K | $81.58 | −$669.1K | −12.2%59.3K after | 2 lots |
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Davis George EricEVP, General Counsel | SSale | −6.13K | $81.29 | −$498.2K | −8.8%63.3K after | |
| Mar 14, 2022 (view filing) | Mar 10-11 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −30.0K | $77.69 | −$2.33M | −8.1%338.6K after | 2 lots |
| Mar 2, 2022 (view filing) | Feb 28 | 2 days | Slamon DennisDirector | SSale | −6.40K | $78.33 | −$501.0K | −22.8%21.6K after | 6 lots |
| Jan 19, 2022 (view filing) | Jan 14 | 5 days | Lawlis V BryanDirector | SSale | −4.25K | $87.61 | −$372.3K | −15.1%24.0K after | |
| Jan 14, 2022 (view filing) | Jan 12-13 | 2 days | Bienaime Jean JacquesChief Executive Officer | SSale | −10.0K | $88.43 | −$884.3K | −3.2%303.8K after | 2 lots |
| Dec 17, 2021 (view filing) | Dec 15-16 | 2 days | Bienaime Jean JacquesChief Executive Officer | SSale | −12.0K | $83.70 | −$1.00M | −3.8%303.7K after | 2 lots |
| Dec 2, 2021 (view filing) | Dec 1 | 1 day | Bienaime Jean JacquesChief Executive Officer | SSale | −1.50K | $87.22 | −$130.8K | −0.5%304.4K after | |
| Oct 28, 2021 (view filing) | Oct 26 | 2 days | Ajer Jeffrey RobertEVP, Chief Commercial Officer | SSale | −2.74K | $73.60 | −$201.6K | −4.7%55.9K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Davis George EricEVP, General Counsel | SSale | −5.52K | $76.69 | −$423.2K | −8.6%58.6K after |